Literature DB >> 15861019

Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.

Way Seah Lee1, Patrick McKiernan, Deirdre Anne Kelly.   

Abstract

OBJECTIVE: To study the etiology, outcome and prognostic indicators in children with fulminant hepatic failure in the United Kingdom.
DESIGN: Retrospective review of all patients <17 years with fulminant hepatic failure from 1991 to 2000. Fulminant hepatic failure was defined as presence of coagulopathy (prothrombin time >24 seconds or International Normalized Ratio >2.0) with or without hepatic encephalopathy within 8 weeks of the onset of symptoms.
SETTING: Liver Unit, Birmingham Children's Hospital, United Kingdom.
RESULTS: Ninety-seven children (48 male, 49 female; median age, 27 months; range, 1 day-192.0 months) were identified with fulminant hepatic failure. The etiologies were: 22 metabolic, 53 infectious, 19 drug-induced, and 3 autoimmune hepatitis. The overall survival rate was 61%. 33% (32/97) recovered spontaneously with supportive management. Fifty-five children were assessed for liver transplantation. Four were unstable and were not listed for liver transplantation; 11 died while awaiting liver transplantation. Liver transplantation was contraindicated in 10 children. Of the 40 children who underwent liver transplantation, 27 survived. Children with autoimmune hepatitis, paracetamol overdose or hepatitis A were more likely to survive without liver transplantation. Children who had a delay between the first symptom of liver disease and the onset of hepatic encephalopathy (median, 10.5 days versus 3.5 days), higher plasma bilirubin (299 micromol/L versus 80 micromol/L), higher prothrombin time (62 seconds versus 40 seconds) or lower alanine aminotransferase (1288 IU/L versus 2929 IU/L) levels on admission were more likely to die of fulminant hepatic failure or require liver transplantation (P < 0.05). On multivariate analysis, the significant independent predictors for the eventual failure of conservative therapy were time to onset of hepatic encephalopathy >7 days, prothrombin time >55 seconds and alanine aminotransferase </=2384 IU/L on admission.
CONCLUSIONS: Children with fulminant hepatic failure with severe coagulopathy, lower alanine aminotransferase on admission and prolonged duration of illness before the onset of hepatic encephalopathy are more likely to require liver transplantation. Early referral to a specialized center for consideration of liver transplantation is vital.

Entities:  

Mesh:

Year:  2005        PMID: 15861019     DOI: 10.1097/01.mpg.0000158524.30294.e2

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  35 in total

Review 1.  Recent advances in liver transplantation for metabolic disease.

Authors:  P J Mc Kiernan
Journal:  J Inherit Metab Dis       Date:  2017-02-06       Impact factor: 4.982

Review 2.  The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children.

Authors:  Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

3.  Characteristics and outcome of autoimmune liver disease in Asian children.

Authors:  Way S Lee; Su H Lum; Chooi B Lim; Sze Y Chong; Kim M Khoh; Ruey T Ng; Kai M Teo; Christopher C M Boey; Jayalakshmi Pailoor
Journal:  Hepatol Int       Date:  2014-08-06       Impact factor: 6.047

4.  Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience.

Authors:  Pierre Bourgoin; Aicha Merouani; Véronique Phan; Catherine Litalien; Michel Lallier; Fernando Alvarez; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2013-12-06       Impact factor: 3.714

Review 5.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

6.  Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing.

Authors:  Baoyan Xu; Ning Zhi; Gangqing Hu; Zhihong Wan; Xiaobin Zheng; Xiaohong Liu; Susan Wong; Sachiko Kajigaya; Keji Zhao; Qing Mao; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 7.  Metabolic Liver Disease: When to Suspect and How to Diagnose?

Authors:  Seema Alam; Vikrant Sood
Journal:  Indian J Pediatr       Date:  2016-04-29       Impact factor: 1.967

8.  Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice.

Authors:  Y Avraham; N C Grigoriadis; I Magen; T Poutahidis; L Vorobiav; O Zolotarev; Y Ilan; R Mechoulam; E M Berry
Journal:  Br J Pharmacol       Date:  2009-09-18       Impact factor: 8.739

9.  Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group.

Authors:  Vicky L Ng; Ruosha Li; Kathleen M Loomes; Mike A Leonis; David A Rudnick; Steven H Belle; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-09       Impact factor: 2.839

10.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.